Bard Associates Inc Sonoma Pharmaceuticals, Inc. Transaction History

Bard Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.23 - $8.89 $243,200 - $413,393	-46,501 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.12 - $9.15 $1,424 - $1,830	200 Added 0.43%	46,501 $341,000
Q3 2020 Nov 12, 2020	SELL	$6.35 - $9.8 $1,905 - $2,940	-300 Reduced 0.64%	46,301 $388,000
Q2 2020 Aug 13, 2020	SELL	$4.72 - $9.7 $25,601 - $52,612	-5,424 Reduced 10.43%	46,601 $332,000
Q1 2020 May 13, 2020	SELL	$3.71 - $6.05 $30,477 - $49,700	-8,215 Reduced 13.64%	52,025 $255,000
Q4 2019 Feb 13, 2020	BUY	$3.94 - $6.45 $237,345 - $388,548	60,240 New	60,240 $262,000
Q4 2019 Feb 13, 2020	SELL	$3.94 - $6.45 $96,805 - $158,476	-24,570 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.01 - $7.8 $12,434 - $19,359	-2,482 Reduced 9.17%	24,570 $142,000
Q2 2019 Aug 13, 2019	BUY	$6.39 - $8.91 $172,862 - $241,033	27,052 New	27,052 $214,000

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.87M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Bard Associates Inc with notifications on news.